Page last updated: 2024-08-26

paxilline and cx 4945

paxilline has been researched along with cx 4945 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwan Kim, S; Kim, J1
Choi, WJ; Jung, J; Kim, J; Kim, SH; Lee, JO; Moon, SH; Park, JK1

Other Studies

2 other study(ies) available for paxilline and cx 4945

ArticleYear
CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Cadherins; Casein Kinase II; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Focal Adhesion Kinase 1; Humans; Lung Neoplasms; Naphthyridines; Neoplasm Invasiveness; Paxillin; Phenazines; Protein Kinase Inhibitors; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Wnt Proteins

2013
Micropillar arrays as potential drug screens: Inhibition of micropillar-mediated activation of the FAK-Src-paxillin signaling pathway by the CK2 inhibitor CX-4945.
    Acta biomaterialia, 2015, Volume: 27

    Topics: Apoptosis; Biological Assay; Casein Kinase II; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Activation; Equipment Design; Equipment Failure Analysis; Focal Adhesion Kinase 1; Humans; Lung Neoplasms; Mechanotransduction, Cellular; Naphthyridines; Paxillin; Phenazines; src-Family Kinases; Tissue Array Analysis; Treatment Outcome

2015